UBS’s Top New Growth at Reasonable Price Stocks to Buy
As the stock market rises and rises, investors start to look for growth stocks that have not yet rallied too much or that do not have nose-bleed valuations. After all, no one wants to…
As the stock market rises and rises, investors start to look for growth stocks that have not yet rallied too much or that do not have nose-bleed valuations. After all, no one wants to…
ThinkstockLast week stock market bubble-mania was rampant. It seemed as though every Wall Street website, network, magazine, TV show, pundit, talking head, you name it, was screaming that the market had hit rarefied air…
With some of the biggest companies in the semiconductor industry set to report numbers this week, the UBS team is giving investors insight into what may happen.
A new research report from the analysts at Cowen focuses on tech stocks that have flexed their muscle and added capacity in the past to be ready for the current and future increased demand.
New research reports from the biotech, health care and medical device teams at Deutsche Bank raise price targets on three top names to buy and include updates on two others.
ThinkstockAfter a week that had almost every possible component for investors, from good earnings to a steep sell-off to numerous geopolitical issues, there was still some sizable insider transactions on both the buy and…
GM sold 2.5 million cars in the second quarter, the most since 2005. A new report from Merrill Lynch highlights the car dealerships as having the most upside for investors.
In a recent research report, UBS specifically mentions six companies that it advises investors not to use an option strategy on, as they expect near-term catalysts to drive the stocks higher.
ThinkstockFor the third time in less than two weeks, one of the top brokerage firms we cover at 24/7 Wall Street has loudly stepped up to the plate and advised investors to buy the top…
A new research report from the Precious Metal team at Credit Suisse noted that gold has rallied 8% year-to-date and that it could have a lot of room to go even higher.
UBS is relatively positive on the homebuilding industry, but the analysts also have lowered the number of stocks rated Buy in their coverage to just four.
With credit levels still at historic lows, and earnings growth gaining traction, there may be some tremendous upside for investors. Merrill Lynch has raised its price targets on three top credit card stocks.
Deutsche Bank still sees strong second-quarter earnings, as well as possible upward revisions to estimates, as a catalyst for oil services stocks.
In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current earnings expectations. But 24/7 Wall St. has one caveat.
In a new research report, the analysts at UBS stick to their year-long preference for the top large cap names in the Internet industry that have reasonable valuations.
The one asset class that has befuddled investors over the past two years has been gold. Here are some of the top gold stocks that are followed by the J.P. Morgan analysts.
A new report from Credit Suisse highlights specific chip and chip equipment stocks rated Outperform that could have solid earnings, with many having the potential to exceed street estimates.
Despite hawkish commentary from the Federal Reserve has tapped the brakes on MLPs, RBC analysts continue to view the fundamental backdrop as highly attractive for investment.
In a new research report from J.P. Morgan, analysts are not only very positive on their top solar names to buy, they are raising price targets on them in front of earnings releases.
A new report from Merrill Lynch highlights the top semiconductor names, and it also points to three stocks the firm is very cautious on. Investors may want to examine their portfolios to see if…